ArticleJournal of hematology & oncology2018

First pediatric experience of SL-401, a CD123-targeted therapy, in patients with blastic plasmacytoid dendritic cell neoplasm: report of three cases.

Weili Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.